Serological markers in inflammatory bowel disease: The pros and cons

Aaron Lerner, Yehuda Shoenfeld*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

12 Scopus citations

Abstract

Accurate serological assays are desirable for the diagnosis of inflammatory bowel disease. Among several serological markers anti-Saccharomyces cerevisiae mannan antibodies and perinuclear antineutrophil cytoplasmic autoantibodies are highly disease specific for Crohn's disease and ulcerative colitis, respectively. Combining the two improves their specificity. Sensitivity, however, is still low. Due to lack of standardization and vast interobserver variability, they cannot be used as the only diagnostic criteria but can assist clinicians in diagnosing and categorizing patients with inflammatory bowel disease as well as in helping them to take therapeutic decisions.

Original languageEnglish
Pages (from-to)103-105
Number of pages3
JournalEuropean Journal of Gastroenterology and Hepatology
Volume14
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Keywords

  • Anti-Saccharomyces cerevisiae mannan antibodies
  • Crohn's disease
  • Inflammatory bowel disease
  • Perinuclear antineutrophil cytoplasmic autoantibodies
  • Ulcerative colitis

Fingerprint

Dive into the research topics of 'Serological markers in inflammatory bowel disease: The pros and cons'. Together they form a unique fingerprint.

Cite this